ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, supplying promising enhancements across many healthcare and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, far more dependable substitute for therapeutic us